Perfil
En la actualidad, Klaus Henning Jensen es Director Médico de Vifor Pharma AG. Anteriormente, el Dr. Jensen ocupó el cargo de Jefe de Área Terapéutica y Desarrollo de la Diabetes en Sanofi. El Dr. Jensen se doctoró en la Universidad de Copenhague y obtuvo un MBA en la Copenhagen Business School.
Antiguos cargos conocidos de Klaus Jensen.
| Empresas | Cargo | Fin |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 01/12/2019 |
| NOVO NORDISK A/S | General Counsel | - |
| VIFOR PHARMA | Chief Tech/Sci/R&D Officer | - |
Formación de Klaus Jensen.
| Copenhagen Business School | Masters Business Admin |
| University of Copenhagen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| SANOFI | Health Technology |
| Empresas privadas | 1 |
|---|---|
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Klaus Jensen
